- Home
- ACON vs BJDX Comparison
ACON vs BJDX Comparison
Compare ACON & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- BJDX
- Stock Information
- Founded
- ACON 2008
- BJDX 2015
- Country
- ACON United States
- BJDX United States
- Employees
- ACON N/A
- BJDX N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- BJDX Medical Specialities
- Sector
- ACON Technology
- BJDX Health Care
- Exchange
- ACON Nasdaq
- BJDX Nasdaq
- Market Cap
- ACON 1.7M
- BJDX 1.8M
- IPO Year
- ACON 2022
- BJDX 2021
- Fundamental
- Price
- ACON $0.11
- BJDX $4.05
- Analyst Decision
- ACON Buy
- BJDX
- Analyst Count
- ACON 2
- BJDX 0
- Target Price
- ACON $1.30
- BJDX N/A
- AVG Volume (30 Days)
- ACON 991.9K
- BJDX 959.8K
- Earning Date
- ACON 11-14-2024
- BJDX 11-07-2024
- Dividend Yield
- ACON N/A
- BJDX N/A
- EPS Growth
- ACON N/A
- BJDX N/A
- EPS
- ACON N/A
- BJDX N/A
- Revenue
- ACON $49,289.00
- BJDX N/A
- Revenue This Year
- ACON N/A
- BJDX N/A
- Revenue Next Year
- ACON $186.36
- BJDX N/A
- P/E Ratio
- ACON N/A
- BJDX N/A
- Revenue Growth
- ACON N/A
- BJDX N/A
- 52 Week Low
- ACON $0.10
- BJDX $3.03
- 52 Week High
- ACON $7.39
- BJDX $1,272.00
- Technical
- Relative Strength Index (RSI)
- ACON 30.75
- BJDX 48.88
- Support Level
- ACON $0.16
- BJDX $4.30
- Resistance Level
- ACON $0.20
- BJDX $5.49
- Average True Range (ATR)
- ACON 0.02
- BJDX 0.67
- MACD
- ACON -0.01
- BJDX 0.11
- Stochastic Oscillator
- ACON 13.37
- BJDX 25.52
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.